MedTrace Logo

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis

NCT02297867 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-04-17

No results posted yet for this study

Summary

The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis.

Conditions

Interventions

DRUG

ADSCs

autologous ADSCs

Sponsors & Collaborators

  • Gwo Xi Stem Cell Applied Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • CMU B Hospital · China Medical University Beigang Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-13
Primary Completion
2017-12-18
Completion
2018-03-27

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297867 on ClinicalTrials.gov